Active	Status	Sponsor type	Region	Phase	Filter
8 Active 2 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LeBlanc, Thomas
NCT04901416: Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS	Completed	1	8	US	DVX201	Coeptis Therapeutics, Duke University	AML, Adult Recurrent, MDS	10/23	06/24
NCT05986682: Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma	Completed	N/A	30	US	Blenrep	Duke University, GlaxoSmithKline	Multiple Myeloma	11/23	11/23
PeKiT, NCT05977387: Pediatric Kidney Transplant	Recruiting	N/A	500	Europe		Imagine Institute	End Stage Renal Disease, Pediatric ALL, Kidney Transplant; Complications	06/24	06/24
NCT05974150: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring	Recruiting	N/A	25	US	Web based survey	Carevive Systems, Inc.	Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer, Acute Myelogenous Leukemia	11/25	12/25
NAVIGATE, NCT06472128: Novel Digital Application for Patients With Acute Leukemia	Recruiting	N/A	200	US	DREAMLAND, VITAL WELLNESS	Massachusetts General Hospital, National Cancer Institute (NCI)	Relapsed Adult Acute Myeloid Leukemia, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia	04/29	04/30
PATH-4, NCT06328127: Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors	Recruiting	N/A	400	US	PATH	Brigham and Women's Hospital, Dana-Farber Cancer Institute, Duke University, H. Lee Moffitt Cancer Center and Research Institute	Hematopoietic Stem Cell Transplant	05/29	05/30
TARGET-PC, NCT06795529: Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer	Not yet recruiting	N/A	400	US	Palliative Care Intervention, "TARGET-PC", Enhanced Usual Care	Massachusetts General Hospital, National Cancer Institute (NCI), Duke University, University of Pennsylvania	Metastatic Breast Cancer	10/29	03/30
SCOPE-L, NCT05237258: Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia	Recruiting	N/A	2300	US	Specialty Palliative Care, Primary Palliative Care	Massachusetts General Hospital, Patient-Centered Outcomes Research Institute	Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia	04/28	04/29

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LeBlanc, Thomas
NCT04901416: Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS	Completed	1	8	US	DVX201	Coeptis Therapeutics, Duke University	AML, Adult Recurrent, MDS	10/23	06/24
NCT05986682: Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma	Completed	N/A	30	US	Blenrep	Duke University, GlaxoSmithKline	Multiple Myeloma	11/23	11/23
PeKiT, NCT05977387: Pediatric Kidney Transplant	Recruiting	N/A	500	Europe		Imagine Institute	End Stage Renal Disease, Pediatric ALL, Kidney Transplant; Complications	06/24	06/24
NCT05974150: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring	Recruiting	N/A	25	US	Web based survey	Carevive Systems, Inc.	Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer, Acute Myelogenous Leukemia	11/25	12/25
NAVIGATE, NCT06472128: Novel Digital Application for Patients With Acute Leukemia	Recruiting	N/A	200	US	DREAMLAND, VITAL WELLNESS	Massachusetts General Hospital, National Cancer Institute (NCI)	Relapsed Adult Acute Myeloid Leukemia, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia	04/29	04/30
PATH-4, NCT06328127: Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors	Recruiting	N/A	400	US	PATH	Brigham and Women's Hospital, Dana-Farber Cancer Institute, Duke University, H. Lee Moffitt Cancer Center and Research Institute	Hematopoietic Stem Cell Transplant	05/29	05/30
TARGET-PC, NCT06795529: Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer	Not yet recruiting	N/A	400	US	Palliative Care Intervention, "TARGET-PC", Enhanced Usual Care	Massachusetts General Hospital, National Cancer Institute (NCI), Duke University, University of Pennsylvania	Metastatic Breast Cancer	10/29	03/30
SCOPE-L, NCT05237258: Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia	Recruiting	N/A	2300	US	Specialty Palliative Care, Primary Palliative Care	Massachusetts General Hospital, Patient-Centered Outcomes Research Institute	Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia	04/28	04/29